Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CLS earnings, NTA seen in line with FY24 expectations

(Sharecast News) - Property investment firm CLS Holdings said on Monday that earnings and net tangible assets were both seen in line with market expectations. CLS said FY24 property valuations were down 5.8% in local currency. However, when including the strengthening of Sterling in the year, valuations were down by 8.3%.

The FTSE 250-listed firm stated valuations across all of its markets "appear to be bottoming out", with Germany and France flat in H2, reflecting greater rental indexation and interest rate reductions supporting valuation yields.

In the UK, the shortening lease to the National Crime Agency at Spring Gardens, one of the largest assets in the group, contributed to half of the UK reduction as the site was valued as an office investment and not yet as a development site.

For the full year, CLS said transaction levels showed strong momentum with letting activity above FY23 levels and "continued healthy rental growth" as it signed 112 leasing deals and secured annual rent of £16.6m at 6.8%, up from £15.5m and 6.9%, respectively.

Total vacancy increased to 12.7%, up from 11.0%, as more high-quality refurbishments were completed in the UK and France, and CLS disposed of five properties for £66.1m, collectively in line with book value as part of its targeted £270.0m disposal programme.

Chief executive Fredrik Widlund said: "In 2024, CLS made meaningful progress with its strategic goals of letting recent refurbishments and executing its refinancing and sales programme.

"With good progress on the redevelopment opportunities in the portfolio, property values bottoming in the second half of 2024, and positive leasing activity since the start of the year, we are confident of delivering improved shareholder value over the near term."

As of 0915 GMT, CLS shares were up 1.07% at 72.97p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.